Patients with heart failure should be taking coenzyme Q10 (CoQ10) supplements according to research presented at the annual meeting of the Heart Failure Association of the European Society of Cardiology. The Q-SYMBIO study looked at the incidence of cardiac events in 420 patients diagnosed with severe heart failure over a two year period. Heart failure has been linked to declining CoQ10 levels. CoQ10 is an oil-soluble substance present in especially high concentrations in our heart, liver and kidney cells. It plays a key role in cellular energy production as well as having antioxidant properties. Participants were randomly assigned to take either CoQ10 100mg three time daily or a placebo supplement. The incidence of cardiac events including hospitalization and death in those taking CoQ10 was reduced by half compared to the placebo group. Surprisingly, patients had fewer side effects from the CoQ10 supplements compared to placebo. Based on this evidence experts are suggesting all patients with heart failure supplement with CoQ10.
In our opinion this finding adds to the growing body of evidence that CoQ10 supplements improve our heart health. Previous studies have shown CoQ10 reduces blood pressure, angina, and risk of heart attack. Furthermore, patients taking some blood pressure drugs or statin medications to lower cholesterol are at greater risk of CoQ10 deficiency. Unfortunately, dietary sources including meat, seafood, soybean oil, sesame seeds and parsley do not provide therapeutic levels of CoQ10 necessary to achieve benefit. If you have cardiovascular disease you should consider taking at least 300mg of CoQ10 daily in 2-3 divided doses. CoQ10 absorption is improved in supplements formulated in soybean oil and by taking this supplement with food. Warfarin (blood thinner) or other medications may interact with CoQ10 so check with your integrative health provider prior to starting this supplement. Our team is available for a consult to help you find the right solution to optimize your heart health.
Additional References:
European Society of Cardiology, Results from the Q-SYMBIO study
Natural Medicines Comprehensive Database. Coenzyme Q10 monograph




























